Tamsulosin + Dutasteride in pharma franchise in Sikkim

Tamsulosin + Dutasteride in PCD pharma franchise in Amaravati

Tamsulosin + Dutasteride in top pharma company in Faridabad

Tamsulosin + Dutasteride in pcd pharma supplier in Meerut

Tamsulosin + Dutasteride in phama franchise company in India
Tamsulosin + Dutasteride in phama distributor in Rajkot

Home/Products /tamsulosin-0-point-4mg-dutasteride-0-point-5mg-tablet

Uriviga D Tablet

Composition : Tamsulosin (0.4mg) + Dutasteride (0.5mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹225/-

Uriviga D Tablet is a combination medication containing Tamsulosin and Dutasteride, primarily used for the treatment of benign prostatic hyperplasia (BPH), a condition where the prostate gland becomes enlarged, leading to difficulty in urination. This formulation helps alleviate symptoms like frequent urination, weak stream, and difficulty starting urination.

Tamsulosin is an alpha-blocker that works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. Dutasteride, a 5-alpha-reductase inhibitor, works by reducing the size of the prostate gland over time by blocking the conversion of testosterone to dihydrotestosterone (DHT), a hormone that contributes to prostate growth. By combining these two medications, Uriviga D offers a comprehensive approach to managing BPH, reducing both the symptoms and the progression of the condition.

This medication helps improve urinary flow and reduces the need for surgery in many men with BPH. It is usually prescribed for long-term management under the supervision of a healthcare provider. It is important to follow the prescribed dosage and report any side effects to the doctor.

Read More

About the Product

Uriviga D Tablet is a combination medication containing Tamsulosin and Dutasteride, primarily used for the treatment of benign prostatic hyperplasia (BPH), a condition where the prostate gland becomes enlarged, leading to difficulty in urination. This formulation helps alleviate symptoms like frequent urination, weak stream, and difficulty starting urination.

Tamsulosin is an alpha-blocker that works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. Dutasteride, a 5-alpha-reductase inhibitor, works by reducing the size of the prostate gland over time by blocking the conversion of testosterone to dihydrotestosterone (DHT), a hormone that contributes to prostate growth. By combining these two medications, Uriviga D offers a comprehensive approach to managing BPH, reducing both the symptoms and the progression of the condition.

This medication helps improve urinary flow and reduces the need for surgery in many men with BPH. It is usually prescribed for long-term management under the supervision of a healthcare provider. It is important to follow the prescribed dosage and report any side effects to the doctor.

Common side effects include dizziness, low blood pressure, fatigue, decreased libido, and erectile dysfunction. Rare side effects may include breast tenderness or enlargement and allergic reactions.

Uriviga D Tablet is indicated for the treatment of benign prostatic hyperplasia (BPH) to reduce symptoms and the need for surgical intervention.

Take as prescribed. Do not stop taking without consulting your doctor. It may cause dizziness; avoid sudden movements.

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation